- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00768417
Availability of Lipids in Almonds in Healthy Individuals
November 15, 2013 updated by: Richard Mattes, Purdue University
Mastication of Almonds: Effects of Lipid Bioaccessibility, Appetite, and Hormone Response
Evidence indicates that almond consumption is associated with multiple health benefits.
However, nuts are commonly excluded from diets on the basis that their high energy content may induce weight gain.
Evidence from numerous studies show that this is not the case, yet the mechanism responsible for the less than predicted effect on weight is unknown.
This study aimed to examine the effects of increased mastication on lipid bioavailability and satiety related peptide released in humans.
Its purpose is to provide valuable mechanistic data to support the results from previous completed clinical studies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This cross-over study consisted of three study periods of four consecutive days separated by at least one week.
During each day of the three study periods, participants were required to consume 55g of almonds split up into 5 g portions.
They were required to chew the almonds 10, 25, or 40 times before swallowing, depending on the treatment.
During each treatment period, all participants followed the same procedures over the four days.
On day one after an overnight fast, participants reported to the laboratory and were presented with 11, 5 gram portions of almonds to chew 10, 25, or 40 times, depending on treatment arm.
The participant remained in the laboratory for 4 hours post-almond consumption for measurements of blood and appetite.
For the remainder of the 4 days, participants consumed all meals in the laboratory and collected all stools passed.
On a separate occasion, recovered particle sizes of masticated almonds were measured by a mechanical sieving process.
Individuals chewed almond samples either 10, 25 or 40 times and expectorated them into sieves.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University, Laboratory forSensory and Ingestive Studies
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
University and community sample
Description
Inclusion Criteria:
- 18-50 years of age
- BMI 20-25 kg/m2
- Full set of healthy teeth
- Weight stable (<3 kg change in past 3 mo)
Exclusion Criteria:
- Smoker
- Eating Disorders or high level of restraint
- Endocrine disorders
- Pregnant or lactating
- Allergic to nuts
- Taking medication likely to confound study outcomes (meds affecting appetite)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Crossover
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Participants
Participants completed all 3-arms of this cross-over design study.
|
Participants were required to chew 55g grams of almonds per day for four days in 11, 5 gram portions.
Almonds were to be chewed 10 times before swallowing.
Other Names:
Participants were required to chew 55g grams of almonds per day for four days in 11, 5 gram portions.
Almonds were to be chewed 25 times before swallowing.
Other Names:
Participants were required to chew 55g grams of almonds per day for four days in 11, 5 gram portions.
Almonds were to be chewed 40 times before swallowing.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Lipid available for absorption as measured by stool collections, appetite measures, blood analysis
Time Frame: 3, 4 day periods
|
3, 4 day periods
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Particle size distribution as measured by mechanical sieving process
Time Frame: 3 separate sessions
|
3 separate sessions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Richard D Mattes, MPH, PhD, RD, Purdue University
- Study Director: Bridget A Cassady, B.S., Purdue University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2006
Primary Completion (Actual)
August 1, 2007
Study Completion (Actual)
August 1, 2007
Study Registration Dates
First Submitted
October 7, 2008
First Submitted That Met QC Criteria
October 7, 2008
First Posted (Estimate)
October 8, 2008
Study Record Updates
Last Update Posted (Estimate)
November 18, 2013
Last Update Submitted That Met QC Criteria
November 15, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0511003189
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on 10 chews
-
Maastricht University Medical CenterRaisio Nutrition Ltd.Completed
-
Marie Stopes InternationalPopulation Council; GRM Futures GroupCompleted
-
Maastricht University Medical CenterRaisio Group; TKI Life Sciences and Health (LSH)RecruitingCardiovascular Diseases | Asthma, AllergicNetherlands
-
Ministry of Health and Population, EgyptCompletedPainful Diabetic NeuropathyEgypt
-
West China HospitalRecruitingAdvanced Solid Tumors | NeoplasmChina
-
West China HospitalRecruitingHPV-positive Oropharyngeal Squamous Cell CarcinomaChina
-
Jas ChahalCompleted
-
BNM Clinic and ResearchCompletedDental Restoration, Permanent
-
Provectus Biopharmaceuticals, Inc.No longer availableCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative TherapyUnited States, Australia
-
Provectus PharmaceuticalsCompleted